- Activity pressure is positive on the latest completed week.
COSM
NASDAQ
Week ended 11 Sep 2026
Weekly Investor Report
Cosmos Health Inc. · Healthcare · Medical Distribution
Latest close
0.2536 USD
-7.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -10.7% below the Trend Line and sits at 7.9% of its 52-week range. The latest completed week returned -7.2%, after a 16.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 30/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
34
out of 100
Latest Close
0.2536 USD
11 Sep 2026
1W Return
-7.2%
latest completed week
4W Return
16.4%
short-term follow-through
12W Return
19.1%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 40.89% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-7.2%
Latest completed week; four-week move 16.4%.
Indicator stack
11/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.89%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Mixed
30/100 conviction; expected move 114.4%.
News sentiment
53/100
28 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.7% below the Trend Line and sits at 7.9% of its 52-week range. The latest completed week returned -7.2%, after a 16.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.07
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 16.4% over four weeks, 19.1% over 12 weeks, and -72.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.00Latest activity-pressure read.
Pressure change506.3%Four-week change in activity pressure.
Leadership-51.00Latest relative-leadership reading.
RS change19.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 11 Sep 2026
Financial statements through 30 Jun 2026
Field coverage 82%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value37/100Relative valuation strength. Underlying universe rank 64; rank 1 is best.
Quality35/100Profitability and accounting quality. Underlying universe rank 66; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth37/100Revenue and earnings growth. Underlying universe rank 64; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.3x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -28.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 10.3% Gross profit retained from each unit of revenue.
- Operating margin
- -24.6% Operating profit retained from revenue.
- Free-cash-flow margin
- -15.5% Free cash flow generated from revenue.
- Return on invested capital
- -39.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 33.8% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -32.8% Net share repurchases relative to market value.
- Shareholder yield
- -32.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningMixed
COSM shows mixed options pressure with a 30/100 conviction score, put-call volume ratio of 1.11, expected move of 114.4%, and Sharemaestro trend signal inactive.
Conviction30/100
Expected move114.4%
Put/call volume1.11
Insider activity13 / 7
13 acquisitions and 7 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment53/100
Weighted news tone is neutral across 28 relevant articles.
10 positive · 15 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move114.4%Nearest-chain priced movement where available.
52-week drawdown-80.8%Distance below the 52-week high.
13-week volatility16.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
20 Mar
17 Apr
15 May
12 Jun
10 Jul
7 Aug
11 Sep
Weeks higher10 of 2616 weeks finished lower.
Best week+37.7%Week of 3 Jul.
Worst week-19.8%Week of 17 Jul.
Latest week-7.2%Week of 11 Sep.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses4
Sharp losses12
Recent vol16.5%13-week weekly-return volatility.
Base vol12.4%52-week weekly-return volatility.
Up/down split18/33Count of positive and negative weeks in the 52-week window.
Average skew10.5% / -8.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average0.6%
Trend breadth70.0%
Trend70.0%active weekly trend signals
MD69.0%positive activity pressure
RS53.0%positive relative leadership
Four-week leaders
IndustryUS Medical Distribution
4-week rank1 / 10
Group average-7.3%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD60.0%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape26/100
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 40.89%Next-week expectancy is negative with a 40.89% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 88; Buyback Yield rank 97 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options44/100COSM shows mixed options pressure with a 30/100 conviction score, put-call volume ratio of 1.11, expected move of 114.4%, and Sharemaestro trend signal inactive.
Mixed · Options-market disagreement · Expected move 114.4% Sentiment53/100Weighted news tone is neutral across 28 relevant articles.
Cosmos Health subsidiary secures 5.2M unit manufacturing deal By Investing.com Insiders13 / 713 acquisitions and 7 disposals in the latest 180-day insider tape.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 11 Sep 2026 | 0.2536 USD | -7.2% | 0.2839 USD | 0.6909 USD | 1.00 | -51.00 | 7.4M | Off |
| 4 Sep 2026 | 0.2732 USD | 21.6% | 0.2883 USD | 0.6982 USD | 0.87 | -49.20 | 19.7M | Off |
| 28 Aug 2026 | 0.2247 USD | 1.4% | 0.2941 USD | 0.7036 USD | 0.67 | -58.86 | 9.9M | Off |
| 21 Aug 2026 | 0.2215 USD | 1.7% | 0.3027 USD | 0.7097 USD | 0.45 | -60.35 | 15.6M | Off |
| 14 Aug 2026 | 0.2179 USD | -6.5% | 0.3119 USD | 0.7161 USD | 0.16 | -63.00 | 10.1M | Off |
| 7 Aug 2026 | 0.233 USD | 8.1% | 0.3221 USD | 0.7234 USD | 0.16 | -61.16 | 18.6M | Off |
| 31 Jul 2026 | 0.2156 USD | 7.9% | 0.3327 USD | 0.7304 USD | 0.31 | -63.15 | 18.8M | Off |
| 24 Jul 2026 | 0.1999 USD | -14.9% | 0.3427 USD | 0.7365 USD | 0.38 | -66.59 | 23.5M | Off |
| 17 Jul 2026 | 0.2348 USD | -19.8% | 0.3531 USD | 0.7448 USD | 0.32 | -62.16 | 41.3M | Off |
| 10 Jul 2026 | 0.2927 USD | 23.5% | 0.3615 USD | 0.7554 USD | 0.22 | -55.23 | 122.3M | Off |
| 3 Jul 2026 | 0.2371 USD | 37.7% | 0.3665 USD | 0.7729 USD | -0.06 | -63.44 | 73.8M | Off |
| 26 Jun 2026 | 0.1722 USD | -19.1% | 0.374 USD | 0.7912 USD | -0.14 | -73.46 | 31.5M | Off |
| 19 Jun 2026 | 0.2129 USD | 1.4% | 0.3896 USD | 0.8093 USD | -0.03 | -69.01 | 218.3M | Off |
| 12 Jun 2026 | 0.21 USD | -16.3% | 0.4051 USD | 0.8286 USD | -0.11 | -68.96 | 27.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.